Improving standards of clinical care in cystic fibrosis

European Respiratory Journal

Volumn 16, Issue 4, 2000, Pages 585-587

  De Boeck, K ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; EDITORIAL; GENE THERAPY; PATIENT CARE; PRIORITY JOURNAL; SODIUM ABSORPTION; STANDARD;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; GENE THERAPY; HUMANS; PSEUDOMONAS INFECTIONS;

EID: 0033768793     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16d02.x     Document Type: Editorial

References (23)

1. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
2. CFTR as a cAMP-dependent regulator of sodium channels
3. Impact of heterogeneity within cultured cells on bacterial invasion: Analysis of Pseudomonas aeruginosa and Salmonella enterica serovar typhi entry into MDCK cells by using a green fluorescent protein-labelled cystic fibrosis transmembrane conductance regulator receptor
4. Pathogenesis of lung disease in cystic fibrosis
5. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
6. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations
7. Sodium 4-phenylbutyrate downregulates Hsc 70: Implications for intracellular trafficking of delta F 508-CFTR
8. Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein
9. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis
10. Human beta-defensin-1 is a saltsensitive antibiotic in lung that is inactivated in cystic fibrosis
11. Improved survival in the Danish center-treated cystic fibrosis patients: Results of aggressive treatment
12. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: A European consensus
13. Treatment of Pseudomonas aeruginosa lung infection in cystic fibrosis with high or conventional doses of ceftazidime
14. Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy
15. Effect of aerosolized recombinant human Dnase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis
16. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group
17. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens
18. Microbiology of sputum from patients at cystic fibrosis centers in United States
19. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995)